In situ gelling systems: A strategy to improve the bioavailability of ophthalmic pharmaceutical formulations

Drug Discovery Today

Volumn 19, Issue 4, 2014, Pages 400-412

  Almeida, Hugo ^a   Amaral, Maria Helena ^a   Lobão, Paulo ^a   Lobo, José Manuel Sousa ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE EYE; CARBOMER; CARBOXYMETHYLCELLULOSE; CELLACEFATE; CHITOSAN; CIPROFLOXACIN; GATIFLOXACIN; GELLAN; GELLING AGENT; HYALURONIC ACID; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; KETOROLAC TROMETAMOL; MACROGOL; METHYLCELLULOSE; PILOCARPINE; POLOXAMER; POLY(METHYL METHACRYLATE); POLYACRYLAMIDE; POLYACRYLIC ACID; POLYCARBOPHIL; POLYGALACTURONIC ACID; POLYLACTIC ACID; POLYMER; POVIDONE; PUERARIN; PULLULAN; SCLEROGLUCAN; UNINDEXED DRUG; XANTHAN; EYE DROPS; GEL;

BIOCOMPATIBILITY; BIODEGRADABILITY; COLLOID; CONJUNCTIVA; CONTROLLED RELEASE FORMULATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; GELATION; HUMAN; HYDROGEL; LACRIMAL DUCT; NONHUMAN; PHYSICOCHEMICAL MODEL; REVIEW; STIMULUS RESPONSE; ANATOMY AND HISTOLOGY; ANIMAL; BIOAVAILABILITY; CHEMISTRY; EYE; GEL; LACRIMAL FLUID; METABOLISM;

ANIMALS; BIOLOGICAL AVAILABILITY; EYE; GELS; HUMANS; OPHTHALMIC SOLUTIONS; POLYMERS; TEARS;

EID: 84899508220     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2013.10.001     Document Type: Review

References (114)

1. A. Ludwig The use of mucoadhesive polymers in ocular drug delivery Adv. Drug Deliv. Rev. 57 2005 1595 1639
2. R.T. Pijls et al. Studies on a new device for drug delivery to the eye Eur. J. Pharm. Biopharm. 59 2005 283 288
3. H. Almeida et al. Applications of poloxamers in ophthalmic pharmaceutical formulations: on overview Expert Opin. Drug Deliv. 10 2013 1223 1237
4. H. Sasaki et al. Delivery of drugs to the eye by topical application Prog. Ret. Eye Res. 15 1996 583 620
5. H.B. Nirmal et al. In-Situ gel: new trends in controlled and sustained drug delivery systems Int. J. Pharm. Tech. Res. 2 2010 1398 1408
6. K.I. Agarwal et al. In-Situ gel formation for ocular drug delivery systems: an overview Asia J. Bio. Pharm. 1 2010 1 7
7. K.D. Champalal, and P. Sushilkumar Current status of ophthalmic in-situ forming hydrogel Int. J. Pharm. Bio. Sci. 3 2012 372 388
8. D. Meisner, and M. Mezei Liposome ocular delivery systems Adv. Drug Deliv. Rev. 16 1995 75 93
9. E. Mohanambal et al. Formulation and evaluation of pH-triggered in situ gelling system of levofloxacin Indian J. Pharm. Educ. Res. 45 2011 58 64
10. ® gellan gum-based ocular delivery system for indomethacin Acta Pharm. 53 2003 251 261
11. A.H. El-Kamel In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate Int. J. Pharm. 241 2002 47 55
12. I.D. Rupenthal et al. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release Int. J. Pharm. 411 2011 69 77
13. P. Bawa et al. Stimuli-responsive polymers and their applications in drug delivery Biomed. Mater. 4 2009 1 15
14. A. Zimmer, and J. Kreuter Microspheres and nanoparticles used in ocular delivery systems Adv. Drug Deliv. Rev. 16 1995 61 73
15. Y. Diebold, and M. Calonge Applications of nanoparticles in ophthalmology Prog. Retin. Eye Res. 29 2010 596 609
16. L. Gan et al. Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers Drug Discov. Today 18 2013 290 297
17. R.C. Nagarwal et al. Polymeric nanoparticulate system: a potential approach for ocular drug delivery J. Control. Release 136 2009 2 13
18. I.P. Kaur et al. Vesicular systems in ocular drug delivery: an overview Int. J. Pharm. 269 2004 1 14
19. M.F. Land, and R.D. Fernald The evolution of eyes Annu. Rev. Neurosci. 15 1992 1 29
20. A. Malhotra et al. Ocular anatomy and cross-sectional imaging of the eye Semin. Ultrasound CT MRI 32 2011 2 13
21. A. Presland, and J. Myatt Ocular anatomy and physiology relevant to anaesthesia Anaesth. Intensive Care Med. 11 2010 438 443
22. C.L. Bourlais et al. Ophthalmic drug delivery systems: recent advances Prog. Retin. Eye Res. 17 1998 33 58
23. D. Smerdon Anatomy of the eye and orbit Curr. Anaesth. Crit. Care 11 2000 286 292
24. G. Raviola The structural basis of the blood-ocular barriers Exp. Eye Res. 25 1977 27 63
25. M. Rolando, and M. Zierhut The ocular surface and tear film and their dysfunction in dry eye disease Surv. Ophthalmol. 45 2001 S203 S210
26. V. Baeyens, and R. Gurny Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations Pharm. Acta Helv. 72 1977 191 202
27. B.B. Patil, and T.C. Dowd Physiological functions of the eye Curr. Anaesth. Crit. Care 11 2000 293 298
28. V. Baeyens et al. Ocular drug delivery in veterinary medicine Adv. Drug Deliv. Rev. 28 1997 335 361
29. C. Wu et al. Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin Yakugaku Zasshi 127 2007 183 191
30. C.G. Wilson Topical drug delivery in the eye Exp. Eye Res. 78 2004 737 743
31. M. Zignani et al. Topical semi-solid drug delivery: kinetics and tolerance of ophthalmic hydrogels Adv. Drug Deliv. Rev. 16 1995 51 60
32. N. Bhattarai et al. Chitosan-based hydrogels for controlled, localized drug delivery Adv. Drug Deliv. Rev. 62 2010 83 99
33. K. Järvinen et al. Ocular absorption following topical delivery Adv. Drug Deliv. Rev. 16 1995 3 19
34. A. Urtti Challenges and obstacles of ocular pharmacokinetics and drug delivery Adv. Drug Deliv. Rev. 58 2006 1131 1135
35. L. Xinming et al. Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: a review Cont. Lens Anterior Eye 31 2008 57 64
36. S.K. Motwani et al. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimization and in vitro characterisation Eur. J. Pharm. Biopharm. 68 2008 513 525
37. De la Fuente et al. Chitosan-based nanostructures: a delivery platform for ocular therapeutics Adv. Drug Deliv. Rev. 62 2010 100 117
38. L. Romanelli et al. Ocular absorption and distribution of bendazac after topical administration to rabbits with different vehicles Life Sci. 54 1994 877 885
39. J.L. Greaves et al. Polymers and the precorneal tear film STP Pharma Sci. 2 1992 13 33
40. M.M.A. Abdel-Mottaleb et al. Preparation and evaluation of fluconazole gels Egypt. J. Biomed. Sci. 23 2007 266 286
41. J.R. Robinson, and G.M. Mlynek Bioadhesive and phase-change polymers for ocular drug delivery Adv. Drug Deliv. Rev. 16 1995 45 50
42. A. Geethalakshmi et al. Temperature triggered in situ gelling system for betaxolol in glaucoma J. App. Pharm. Sci. 3 2013 153 159
43. G. Sandri et al. Platelet lysate formulations based on mucoadhesive polymers for the treatment of corneal lesions J. Pharm. Pharmacol. 63 2011 189 198
44. K. Al-Tahami, and J. Singh Smart polymer based delivery systems for peptides and proteins Recent Pat. Drug Deliv. Formul. 1 2007 65 71
45. H. Almeida et al. Temperature and pH stimuli-responsive polymers and their applications in controlled and self-regulated drug delivery J. Appl. Pharm. Sci. 2 2012 01 10
46. B. Jeong, and A. Gutowska Lessons from nature: stimuli-responsive polymers and their biomedical applications Trends Biotechnol. 20 2002 305 310
47. A. Kumar et al. Smart polymers: physical forms and bioengineering applications Prog. Polym. Sci. 32 2007 1205 1237
48. P. Gupta et al. Hydrogels: from controlled release to pH-responsive drug delivery Drug Discov. Today 7 2002 569 579
49. J. Kopecek Hydrogel biomaterials: a smart future? Biomaterials 28 2007 5185 5192
50. S. Kim et al. Engineered polymers for advanced drug delivery Eur. J. Pharm. Biopharm. 71 2009 420 430
51. M.A.C. Stuart et al. Emerging applications of stimuli-responsive polymer materials Nat. Mater. 9 2010 101 113
52. E.J. Ricci et al. Sustained release of lidocaine from poloxamer 407 gels Int. J. Pharm. 288 2005 235 244
53. I.M. El-Bagory et al. Effect of gamma irradiation on pluronic gels for ocular delivery of ciprofloxacin: in vitro evaluation Aust. J. Basic Appl. Sci. 4 2010 4490 4498
54. ® F-127 and Pluronic Lecithin Organogel (PLO): main features and their applications in topical and transdermal administration of drugs J. Pharm. Pharm. Sci. 15 2012 592 605
55. A.K. Bajpai et al. Responsive polymers in controlled drug delivery Prog. Polym. Sci. 33 2008 1088 1118
56. L.R. Fogueri, and S. Singh Smart polymers for controlled delivery of proteins and peptides: a review of patents Recent Pat. Drug Deliv. Formul. 3 2009 40 48
57. M.R. Aguilar et al. Smart polymers and their applications as biomaterials Topics Tissue Eng. 3 2007 1 27
58. H. Hosseinzadeh et al. Chitosan-pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study Int. J. Nanomed. 7 2012 1851 1863
59. F. Ruchatz et al. The Combination of Pluronic F127 and Pluronic F68: A New Perspective for Thermogelling Drug Delivery Formulations 2012 BASF Corporation
60. J.J. Escobar-Chávez et al. Applications of thermoreversible Pluronic F-127 gels in pharmaceutical formulations J. Pharm. Pharm. Sci. 9 2006 339 358
61. S.D. Desai, and J. Blanchard Evaluation of Pluronic F 127-based sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model J. Pharm. Sci. 87 1998 1190 1195
62. D.H. Shastri et al. Thermoreversible mucoadhesive ophthalmic in situ hydrogel: design and optimization using a combination of polymers Acta Pharm. 60 2010 349 360
63. D.H. Shastri et al. Studies on in situ hydrogel: a smart way for safe and sustained ocular drug delivery J. Young Pharm. 2 2010 116 120
64. K. Leszczyńka et al. Potential of ceragenin CSA-13 and its mixture with pluronic F127 as treatment of topical bacterial infections J. Appl. Microbiol. 110 2011 229 238
65. G. Wei et al. Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies J. Control. Release 83 2002 65 74
66. L. Mayol et al. A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties Eur. J. Pharm. Biopharm. 70 2008 199 206
67. S. Vodithala et al. Development and evaluation of thermoreversible ocular gels of ketorolac tromethamine Int. J. Biopharm. 1 2010 39 45
68. G. Darwhekar et al. Development and optimization of dorzolamide hydrochloride and timolol maleate in situ gel for glaucoma treatment Asian J. Pharm. Anal. 1 2011 93 97
69. Y. Chen et al. Ocular delivery of cyclosporine A based on glyceryl monooleate/poloxamer 407 liquid crystalline nanoparticles: preparation, characterization, in vitro corneal penetration and ocular irritation J. Drug. Target. 20 2012 856 863
70. S. Miyazaki et al. In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride Int. J. Pharm. 229 2001 29 36
71. S.S. Kulkarni, and N.H. Aloorkar Smart polymers in drug delivery: an overview J. Pharm. Res. 3 2010 100 108
72. G.H. Hsiue et al. Preparation of controlled release ophthalmic drops, for glaucoma therapy using thermosensitive poly-N-isopropylacrylamide Biomaterials 23 2002 457 462
73. C.H. Lee et al. Thixotropic property in pharmaceutical formulations J. Control. Release 136 2009 88 98
74. J. You et al. Bioresponsive matrices in drug delivery J. Biol. Eng. 4 2010 1 12
75. V. Hartmann, and S. Keipert Physico-chemical, in vitro and in vivo characterization of polymers for ocular use Pharmazie 55 2000 440 443
76. S.T. Grainger, and M.E.H. El-Sayed Stimuli-sensitive particles for drug delivery E. Jabbari, A. Khademhosseini, Biologically-Responsive Hybrid Biomaterials: A Reference for Material Scientists and Bioengineers 2010 171 189
77. E.S. Gil, and S.M. Hudson Stimuli-responsive polymers and their bioconjugates Prog. Polym. Sci. 29 2004 1173 1222
78. R.D. Schoenwald et al. Influence of high-viscosityvehicles on miotic effect of pilocarpine J. Pharm. Sci. 69 1978 1280 1283
79. S. Kumar, and K.J. Himmelstein Modification of in situ gelling behavior of carbopol solutions by hydroxypropyl methyl cellulose J. Pharm. Sci. 84 1995 344 348
80. B. Srividya et al. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system J. Control. Release 73 2001 205 211
81. S. Kumar et al. In situ-forming gels for ophthalmic drug delivery J. Ocul. Pharmacol. 10 1995 47 56
82. H. Wu et al. Design and evaluation of baicalin-containing in situ pH-triggered gelling system for sustained ophthalmic drug delivery Int. J. Pham. 410 2011 31 40
83. A.M. Durrani et al. Pilocarpine bioavailability from a mucoadhesive liposomal ophthalmic drug delivery system Int. J. Pharm. 88 1992 409 415
84. M. Oechsner, and S. Keipert Polyacrylic acid/polyvinylpyrrolidone bipolymeric systems. I. Rheological and mucoadhesive properties of formulations potentially useful for the treatment of dry-eye-syndrome Eur. J. Pharm. Biopharm. 47 1999 113 118
85. K.L. Krenzer et al. Safety of repeated topical ocular administration of a polycarbophil-based formulation in several models of ocular surgery in rabbits J. Cataract Refract. Surg. 38 2012 696 704
86. C.M. Lehr et al. Improved ocular penetration of gentamicin by mucoadhesive polymer polycarbophil in the pigmented rabbit Invest. Ophthalmol. Vis. Sci. 35 1994 2809 2814
87. M.S. Nagarsenker et al. Preparation of liposomal formulation of tropicamide for ocular delivery Int. J. Pharm. 190 1999 63 71
88. M.D. Hornof, and A. Bernkop-Schnürch In vitro evaluation of the permeation enhancing effect of polycarbophil-cysteine conjugates on the cornea of rabbits J. Pharm. Sci. 91 2002 2588 2592
89. V.R. Sinha et al. Chitosan microspheres as a potential carrier for drugs Int. J. Pharm. 274 2004 1 33
90. S. Majumdar et al. Effect of chitosan, benzalkonium chloride and ethylenediaminetetraacetic acid on permeation of acyclovir across isolated rabbit cornea Int. J. Pharm. 348 2008 175 178
91. I. Genta et al. Bioadhesive microspheres for ophthalmic administration of acyclovir J. Pharm. Pharmacol. 49 1997 737 742
92. P. Calvo et al. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers Int. J. Pharm. 153 1997 41 50
93. O. Felt et al. Topical use of chitosan in ophthalmology: tolerance, assessment and evaluation of precorneal retention Int. J. Pharm. 180 1999 185 193
94. A.M. De Campos et al. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A Int. J. Pharm. 224 2001 159 168
95. Y. Diebold et al. Ocular drug delivery by liposome-chitosan nanoparticles complexes (LCS-NP) Biomaterials 28 2007 1553 1564
96. X.B. Yuan et al. Preparation of rapamycin-loaded chitosan/PLA nanoparticles for immunosuppression in corneal transplantation Int. J. Pharm. 349 2008 241 248
97. N. Li et al. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery Int. J. Pharm. 379 2009 131 138
98. Q. Luo et al. Nanostructured lipid carrier (NLC) coated with chitosan oligosaccharides and its potential use in ocular drug delivery system Int. J. Pharm. 403 2011 185 191
99. R. Gurny Preliminary study of prolonged acting drug delivery systems for the treatment of glaucoma Pharm. Acta Helv. 156 1981 130 132
100. R. Gurny et al. Ocular therapy with nanoparticulate systems for controlled drug delivery J. Control. Release 2 1985 353 361
101. ®) in physiological conditions Eur. J. Pharm. Sci. 9 1999 99 105
102. A. Rozier et al. Gelrite: a novel, ion-activated. in situ gelling polymer for ophthalmic vehicles: effect on bioavailability of timolol Int. J. Pharm. 57 1989 163 168
103. ® in situ gels for ophthalmic use Eur. J. Pharm. Sci. 6 1998 105 112
104. K. Dickstein et al. Comparison of aqueous and gellan ophthalmic timolol with placebo on the 24-hour heart rate response in patients on treatment for glaucoma Am. J. Ophthalmol. 132 2001 626 632
105. S.A. Tayel et al. Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits Int. J. Pharm. 443 2013 293 305
106. H. Qi et al. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin Int. J. Pharm. 337 2007 178 187
107. J. Varshosaz et al. Designing of a thermoreversible chitosan/poloxamer in situ gel for ocular delivery of ciprofloxacin Open Drug Deliv. J. 2 2008 61 70
108. S. Gupta, and S.P. Vyas Carbopol/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate Sci. Pharm. 78 2010 959 976
109. T. Gratieri et al. A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery Eur. J. Pharm. Biopharm. 75 2010 186 193
110. S. Gupta et al. Dual-drug delivery system based on in-situ gel-forming nanosuspension of forskolin to enhance antiglaucoma efficacy AAPS Pharm. SciTech. 11 2010 322 335
111. G.K. Jain et al. Microscopic and spectroscopic evaluation of novel PLGA-chitosan nanoplexes as an ocular delivery system Colloids Surf. B82 397 2011 403
112. T. Gratieri et al. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel Eur. J. Pharm. Biopharm. 79 2011 320 327
113. M. Gallarate et al. Development of O/W nanoemulsions for ophthalmic administration of timolol.Int J. Pharm. 440 2013 126 134
114. N. Dilbaghi et al. Evaluation of tropicamide-loaded tamarind seed xyloglucan nanoaggregates for ophthalmic delivery Carbohydr. Polym. 94 2013 286 291